Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, William A., Hanuš, Lumir, Breuer, Aviva, Pertwee, Roger G., Stevenson, Lesley A., Griffin, Graeme, Gibson, Dan, Mandelbaum, Asher +2 more·1992·Science

Cited by (203)

Items 101–200 of 203

  1. Regulation of endocannabinoid signaling by stress: Implications for stress-related affective disorders
    Gorzalka, Boris B., Hill, Matthew N., Hillard, Cecilia J. · 2008 · Neuroscience & Biobehavioral Reviews
  2. Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels
    Micale, Vincenzo, Cristino, Luigia, Tamburella, Alessandra, Petrosino, Stefania, Leggio, Gian Marco, Drago, Filippo, Di Marzo, Vincenzo · 2009 · Neuropsychopharmacology
  3. The endogenous cannabinoid system and its role in nociceptive behavior
    Cravatt, Benjamin F., Lichtman, Aron H. · 2004 · Journal of Neurobiology
  4. Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators.
    Bradshaw, Heather B., Rimmerman, Neta, Krey, Jocelyn F., Walker, J. Michael · 2006 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  5. Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals
    Re, G., Barbero, R., Miolo, A., Di Marzo, V. · 2007 · The Veterinary Journal
  6. Cyclooxygenase-2 in synaptic signaling
    Yang, Hongwei, Chen, Chu · 2008 · Current Pharmaceutical Design
  7. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons
    Guo, Juan, Ikeda, Stephen R. · 2004 · Molecular Pharmacology
  8. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors
    Melck, Dominique, Bisogno, Tiziana, De Petrocellis, Luciano, Chuang, Huai-hu, Julius, David, Bifulco, Maurizio, Di Marzo, Vincenzo · 1999 · Biochemical and Biophysical Research Communications
  9. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
    Maccarrone, Mauro, Di Marzo, Vincenzo, Gertsch, Jürg, Grether, Uwe, Howlett, Allyn C., Hua, Tian, Makriyannis, Alexandros, Piomelli, Daniele, Ueda, Natsuo, van der Stelt, Mario · 2023 · Pharmacological Reviews
  10. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice
    Russo, Roberto, LoVerme, Jesse, La Rana, Giovanna, Compton, Timothy R., Parrott, Jeff, Duranti, Andrea, Tontini, Andrea, Mor, Marco, Tarzia, Giorgio, Calignano, Antonio et al. · 2007 · The Journal of Pharmacology and Experimental Therapeutics
  11. Endocannabinoid signalling: has it got rhythm?
    Vaughn, Linda K, Denning, Gerene, Stuhr, Kara L, de Wit, Harriet, Hill, Matthew N, Hillard, Cecilia J · 2010 · British Journal of Pharmacology
  12. Cannabinoids and anxiety
    Moreira, Fabrício A., Wotjak, Carsten T. · 2009 · Current topics in behavioral neurosciences
  13. Cannabinoid analgesia
    Walker, J.Michael, Huang, Susan M · 2002 · Pharmacology & Therapeutics
  14. A catalytically silent FAAH-1 variant drives anandamide transport in neurons
    Fu, Jin, Bottegoni, Giovanni, Sasso, Oscar, Bertorelli, Rosalia, Rocchia, Walter, Masetti, Matteo, Guijarro, Ana, Lodola, Alessio, Armirotti, Andrea, Garau, Gianpiero et al. · 2012 · Nature Neuroscience
  15. Beyond THC and Endocannabinoids
    Pacher, Pal, Kogan, Natalya M., Mechoulam, Raphael · 2020 · Annual Review of Pharmacology and Toxicology
  16. The <i>N</i>‐Acylethanolamine‐Hydrolyzing Acid Amidase (NAAA)
    Tsuboi, Kazuhito, Takezaki, Naoko, Ueda, Natsuo · 2007 · Chemistry &amp; Biodiversity
  17. Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells
    Klein, Thomas W., Cabral, Guy A. · 2006 · Journal of Neuroimmune Pharmacology
  18. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay
    Kinsey, Steven G., O'Neal, Scott T., Long, Jonathan Z., Cravatt, Benjamin F., Lichtman, Aron H. · 2011 · Pharmacology Biochemistry and Behavior
  19. Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation
    Patel, Sachin, Hillard, Cecilia J. · 2008 · European Journal of Neuroscience
  20. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: Effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment
    Guindon, Josée, Lai, Yvonne, Takacs, Sara M., Bradshaw, Heather B., Hohmann, Andrea G. · 2013 · Pharmacological Research
  21. The Biodisposition and Metabolism of Anandamide in Mice
    Willoughby, Karen A., Moore, Sandra F., Martin, Billy R., Ellis, Earl F. · 1997 · The Journal of Pharmacology and Experimental Therapeutics
  22. Discovery and Characterization of a Ca2+-independent Phosphatidylethanolamine N-Acyltransferase Generating the Anandamide Precursor and Its Congeners
    Jin, Xing-Hua, Okamoto, Yasuo, Morishita, Jun, Tsuboi, Kazuhito, Tonai, Takeharu, Ueda, Natsuo · 2007 · Journal of Biological Chemistry
  23. Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms
    Chang, Leon, Luo, Lin, Palmer, James A, Sutton, Steven, Wilson, Sandy J, Barbier, Ann J, Breitenbucher, James Guy, Chaplan, Sandra R, Webb, Michael · 2006 · British Journal of Pharmacology
  24. Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
    Korpi, Esa R., den Hollander, Bjørnar, Farooq, Usman, Vashchinkina, Elena, Rajkumar, Ramamoorthy, Nutt, David J., Hyytiä, Petri, Dawe, Gavin S. · 2015 · Pharmacological Reviews
  25. Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats
    Lemos, José Inácio, Resstel, Leonardo Barbosa, Guimarães, Francisco Silveira · 2010 · Behavioural Brain Research
  26. Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
    Alves, Patrícia, Amaral, Cristina, Teixeira, Natércia, Correia-da-Silva, Georgina · 2020 · Pharmacological Research
  27. Inhibition of Fatty Acid Binding Proteins Elevates Brain Anandamide Levels and Produces Analgesia
    Kaczocha, Martin, Rebecchi, Mario J., Ralph, Brian P., Teng, Yu-Han Gary, Berger, William T., Galbavy, William, Elmes, Matthew W., Glaser, Sherrye T., Wang, Liqun, Rizzo, Robert C. et al. · 2014 · PLoS ONE
  28. The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice
    Barna, I., Zelena, D., Arszovszki, A.C., Ledent, C. · 2004 · Life Sciences
  29. What do we (not) know about how paracetamol (acetaminophen) works?: Paracetamol’s analgesic mechanism?
    Toussaint, K., Yang, X. C., Zielinski, M. A., Reigle, K. L., Sacavage, S. D., Nagar, S., Raffa, R. B. · 2010 · Journal of Clinical Pharmacy and Therapeutics
  30. Cannabis and the developing brain: Insights from behavior
    Trezza, Viviana, Cuomo, Vincenzo, Vanderschuren, Louk J.M.J. · 2008 · European Journal of Pharmacology
  31. Candidate genes for cannabis use disorders: findings, challenges and directions.
    Agrawal, Arpana, Lynskey, Michael T. · 2009 · Addiction
  32. More surprises lying ahead. The endocannabinoids keep us guessing
    Piomelli, Daniele · 2014 · Neuropharmacology
  33. Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
    Patricio, Felipe, Morales-Andrade, Alan Axel, Patricio-Martínez, Aleidy, Limón, Ilhuicamina Daniel · 2020 · Frontiers in Pharmacology
  34. The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model
    Ghosh, Sudeshna, Wise, Laura E., Chen, Yugang, Gujjar, Ramesh, Mahadevan, Anu, Cravatt, Benjamin F., Lichtman, Aron H. · 2013 · Life Sciences
  35. T-Type Calcium Channel Inhibition Underlies the Analgesic Effects of the Endogenous Lipoamino Acids
    Barbara, Guillaume, Alloui, Abdelkrim, Nargeot, Joël, Lory, Philippe, Eschalier, Alain, Bourinet, Emmanuel, Chemin, Jean · 2009 · The Journal of Neuroscience
  36. Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals
    Nyilas, Rita, Dudok, Barna, Urbán, Gabriella M., Mackie, Ken, Watanabe, Masahiko, Cravatt, Benjamin F., Freund, Tamás F., Katona, István · 2008 · The Journal of Neuroscience
  37. Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine
    Vela, G., Ruiz-gayo, M., Fuentes, J.A. · 1995 · Neuropharmacology
  38. Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibitors Produce Anti-Allodynic Effects in Mice Through Distinct Cannabinoid Receptor Mechanisms
    Kinsey, Steven G., Long, Jonathan Z., Cravatt, Benjamin F., Lichtman, Aron H. · 2010 · The Journal of Pain
  39. The fatty acid amide hydrolase (FAAH) inhibitor PF‐3845 acts in the nervous system to reverse LPS‐induced tactile allodynia in mice
    Booker, Lamont, Kinsey, Steven G, Abdullah, Rehab A, Blankman, Jacqueline L, Long, Jonathan Z, Ezzili, Cyrine, Boger, Dale L, Cravatt, Benjamin F, Lichtman, Aron H · 2012 · British Journal of Pharmacology
  40. Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines
    Kuepper, Rebecca, Morrison, Paul D., van Os, Jim, Murray, Robin M., Kenis, Gunter, Henquet, Cécile · 2010 · Schizophrenia Research
  41. Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain
    Cristino, L., Starowicz, K., De Petrocellis, L., Morishita, J., Ueda, N., Guglielmotti, V., Di Marzo, V. · 2008 · Neuroscience
  42. Enzymological studies on the biosynthesis of N-acylethanolamines
    Ueda, Natsuo, Tsuboi, Kazuhito, Uyama, Toru · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  43. Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors
    Soares, Vanessa de Paula, Campos, Alline Cristina, Bortoli, Valquíria Camin de, Zangrossi, Hélio, Guimarães, Francisco Silveira, Zuardi, Antonio Waldo · 2010 · Behavioural Brain Research
  44. Physical activity and the endocannabinoid system: an overview
    Tantimonaco, Mirko, Ceci, Roberta, Sabatini, Stefania, Catani, Maria Valeria, Rossi, Antonello, Gasperi, Valeria, Maccarrone, Mauro · 2014 · Cellular and Molecular Life Sciences
  45. Localization of <i>N</i>‐acyl phosphatidylethanolamine phospholipase D (NAPE‐PLD) expression in mouse brain: A new perspective on <i>N</i>‐acylethanolamines as neural signaling molecules
    Egertová, Michaela, Simon, Gabriel M., Cravatt, Benjamin F., Elphick, Maurice R. · 2008 · Journal of Comparative Neurology
  46. Cannabinoids modulate pain by multiple mechanisms of action
    Richardson, Jennelle Durnett · 2000 · The Journal of Pain
  47. Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial
    Pini, Luigi Alberto, Guerzoni, Simona, Cainazzo, Maria Michela, Ferrari, Anna, Sarchielli, Paola, Tiraferri, Ilaria, Ciccarese, Michela, Zappaterra, Maurizio · 2012 · The Journal of Headache and Pain
  48. Nicotine and cannabinoids: parallels, contrasts and interactions
    VIVEROS, M, MARCO, E, FILE, S · 2006 · Neuroscience &amp; Biobehavioral Reviews
  49. Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice
    Yamaguchi, Taku, Hagiwara, Yumi, Tanaka, Hiroyuki, Sugiura, Takayuki, Waku, Keizo, Shoyama, Yukihiro, Watanabe, Shigenori, Yamamoto, Tsuneyuki · 2001 · Brain Research
  50. Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients With Nonconstipated Irritable Bowel Syndrome
    Wong, Banny S., Camilleri, Michael, Busciglio, Irene, Carlson, Paula, Szarka, Lawrence A., Burton, Duane, Zinsmeister, Alan R. · 2011 · Gastroenterology
  51. Fatty Acid Amide Hydrolase: A Gate-Keeper of the Endocannabinoid System
    Fezza, Filomena, De Simone, Chiara, Amadio, Daniele, Maccarrone, Mauro · 2008 · Subcellular Biochemistry
  52. Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala–hippocampal–prefrontal circuit
    Ganon-Elazar, Eti, Akirav, Irit · 2013 · Psychoneuroendocrinology
  53. The inhibition of monoacylglycerol lipase by URB602 showed an anti‐inflammatory and anti‐nociceptive effect in a murine model of acute inflammation
    Comelli, F, Giagnoni, G, Bettoni, I, Colleoni, M, Costa, B · 2007 · British Journal of Pharmacology
  54. Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions
    Sasso, Oscar, Bertorelli, Rosalia, Bandiera, Tiziano, Scarpelli, Rita, Colombano, Giampiero, Armirotti, Andrea, Moreno-Sanz, Guillermo, Reggiani, Angelo, Piomelli, Daniele · 2012 · Pharmacological Research
  55. Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness
    Koethe, Dagmar, Gerth, Christoph W., Neatby, Miriam A., Haensel, Anita, Thies, Martin, Schneider, Udo, Emrich, Hinderk M., Klosterkötter, Joachim, Schultze-Lutter, Frauke, Leweke, F. Markus · 2006 · Schizophrenia Research
  56. Endocannabinoid-mediated synaptic plasticity and addiction-related behavior
    Sidhpura, Nimish, Parsons, Loren H. · 2011 · Neuropharmacology
  57. Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain
    Guindon, Josée, Beaulieu, Pierre · 2006 · Neuropharmacology
  58. Endocannabinoids and pregnancy.
    Taylor, Anthony H., Amoako, Akwasi A., Bambang, Katerina, Karasu, Tulay, Gebeh, Alpha, Lam, Patricia M.W., Marzcylo, Timothy H., Konje, Justin C. · 2010 · Clinica Chimica Acta
  59. The Blockade of the Transient Receptor Potential Vanilloid Type 1 and Fatty Acid Amide Hydrolase Decreases Symptoms and Central Sequelae in the Medial Prefrontal Cortex of Neuropathic Rats
    de Novellis, Vito, Vita, Daniela, Gatta, Luisa, Luongo, Livio, Bellini, Giulia, De Chiaro, Maria, Marabese, Ida, Siniscalco, Dario, Boccella, Serena, Piscitelli, Fabiana et al. · 2011 · Molecular Pain
  60. Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration
    Matias, I., Wang, J.W., Moriello, A. Schiano, Nieves, A., Woodward, D.F., Di Marzo, V. · 2006 · Prostaglandins Leukotrienes and Essential Fatty Acids
  61. Potentiation of Δ9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of μ- and κ-opioid receptors
    Reche, Ignacio, Fuentes, José A, Ruiz-Gayo, Mariano · 1996 · European Journal of Pharmacology
  62. Body Mass Index and Marijuana Use
    Warren, Matthew, Frost-Pineda, Kimberly, Gold, Mark · 2005 · Journal of Addictive Diseases
  63. Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system
    Palazzo, Enza, De Novellis, Vito, Petrosino, Stefania, Marabese, Ida, Vita, Daniela, Giordano, Catia, Di Marzo, Vincenzo, Mangoni, Giuseppe Salvatore, Rossi, Francesco, Maione, Sabatino · 2006 · European Journal of Neuroscience
  64. Global strategies to integrate the proteome and metabolome
    Saghatelian, Alan, Cravatt, Benjamin F · 2005 · Current Opinion in Chemical Biology
  65. Chapter 5 The Endocannabinoid System as A Target for Novel Anxiolytic and Antidepressant Drugs
    Gaetani, Silvana, Dipasquale, Pasqua, Romano, Adele, Righetti, Laura, Cassano, Tommaso, Piomelli, Daniele, Cuomo, Vincenzo · 2009 · International Review of Neurobiology
  66. Endocannabinoids at the synapse a decade after the <i>dies mirabilis</i> (29 March 2001): what we still do not know
    Alger, Bradley E. · 2012 · The Journal of Physiology
  67. Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse
    González, Sara, Valenti, Marta, de Miguel, Rosario, Fezza, Filomena, Fernández‐Ruiz, Javier, Di Marzo, Vincenzo, Ramos, José A · 2004 · British Journal of Pharmacology
  68. Involvement of the opioid and cannabinoid systems in pain control: New insights from knockout studies
    Nadal, Xavier, La Porta, Carmen, Andreea Bura, S., Maldonado, Rafael · 2013 · European Journal of Pharmacology
  69. Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents
    Hill, Matthew N., Ho, Wing-Sze Vanessa, Hillard, Cecilia J., Gorzalka, Boris B. · 2008 · Journal of Neural Transmission
  70. Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase
    Karbarz, Mark J., Luo, Lin, Chang, Leon, Tham, Chui-Se, Palmer, James A., Wilson, Sandy J., Wennerholm, Michelle L., Brown, Sean M., Scott, Brian P., Apodaca, Richard L. et al. · 2009 · Anesthesia &amp; Analgesia
  71. Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters
    Wood, JodiAnne T., Williams, John S., Pandarinathan, Lakshmipathi, Courville, Amber, Keplinger, Melissa R., Janero, David R., Vouros, Paul, Makriyannis, Alexandros, Lammi-Keefe, Carol J. · 2008 · Clinical Chemistry and Laboratory Medicine
  72. Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 receptors.
    Haj-Dahmane, Samir, Shen, Roh-Yu · 2009 · The Journal of Pharmacology and Experimental Therapeutics
  73. Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive
    Sasso, Oscar, Wagner, Karen, Morisseau, Christophe, Inceoglu, Bora, Hammock, Bruce D., Piomelli, Daniele · 2015 · Pharmacological Research
  74. Cav3.2 calcium channels: The key protagonist in the supraspinal effect of paracetamol
    Kerckhove, Nicolas, Mallet, Christophe, François, Amaury, Boudes, Mathieu, Chemin, Jean, Voets, Thomas, Bourinet, Emmanuel, Alloui, Abdelkrim, Eschalier, Alain · 2014 · Pain
  75. Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats
    Campos, Alline Cristina, de Paula Soares, Vanessa, Carvalho, Milene C, Ferreira, Frederico Rogerio, Vicente, Maria Adrielle, Brandão, Marcus Lira, Zuardi, Antonio Waldo, Zangrossi, Hélio, Guimarães, Francisco Silveira · 2013 · Psychopharmacology
  76. Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock‐probe burying test
    Degroot, Aldemar, Nomikos, George G. · 2004 · European Journal of Neuroscience
  77. The neurobiology of social play behaviour: Past, present and future
    Achterberg, E.J. Marijke, Vanderschuren, Louk J.M.J. · 2023 · Neuroscience &amp; Biobehavioral Reviews
  78. Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice
    Ghosh, Sudeshna, Kinsey, Steven G., Liu, Qing-song, Hruba, Lenka, McMahon, Lance R., Grim, Travis W., Merritt, Christina R., Wise, Laura E., Abdullah, Rehab A., Selley, Dana E. et al. · 2015 · The Journal of Pharmacology and Experimental Therapeutics
  79. Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic–pituitary–adrenal axis responses in male Sprague–Dawley rats
    Newsom, R.J., Osterlund, C., Masini, C.V., Day, H.E., Spencer, R.L., Campeau, S. · 2012 · Neuroscience
  80. [123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Δ9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patients
    Berding, Georg, Müller-Vahl, Kirsten, Schneider, Udo, Gielow, Peter, Fitschen, Jürgen, Stuhrmann, Manfred, Harke, Heinrich, Buchert, Ralph, Donnerstag, Frank, Hofmann, Michael et al. · 2004 · Biological Psychiatry
  81. Functional Metabolomics Reveals Novel Active Products in the DHA Metabolome
    Shinohara, Masakazu, Mirakaj, Valbona, Serhan, Charles N. · 2012 · Frontiers in Immunology
  82. Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models
    Grim, Travis W., Ghosh, Sudeshna, Hsu, Ku-Lung, Cravatt, Benjamin F., Kinsey, Steven G., Lichtman, Aron H. · 2014 · Pharmacology Biochemistry and Behavior
  83. Do Endocannabinoids Cause the Runner’s High? Evidence and Open Questions
    Siebers, Michael, Biedermann, Sarah V., Fuss, Johannes · 2023 · The Neuroscientist
  84. Endocannabinoid signaling in synchronizing embryo development and uterine receptivity for implantation.
    Paria, B.C., Wang, H., Dey, S.K. · 2002 · Chemistry and Physics of Lipids
  85. Colonization with the commensal fungus candida albicans perturbs the gut-brain axis through dysregulation of endocannabinoid signaling
    Markey, Laura, Hooper, Andrew, Melon, Laverne C., Baglot, Samantha, Hill, Matthew N., Maguire, Jamie, Kumamoto, Carol A. · 2020 · Psychoneuroendocrinology
  86. Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice
    Schlosburg, Joel E., Kinsey, Steven G., Ignatowska-Jankowska, Bogna, Ramesh, Divya, Abdullah, Rehab A., Tao, Qing, Booker, Lamont, Long, Jonathan Z., Selley, Dana E., Cravatt, Benjamin F. et al. · 2014 · The Journal of Pharmacology and Experimental Therapeutics
  87. Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice
    Gamage, Thomas F., Ignatowska-Jankowska, Bogna M., Muldoon, Pretal P., Cravatt, Benjamin F., Damaj, M. Imad, Lichtman, Aron H. · 2015 · Drug and Alcohol Dependence
  88. Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray
    Almeida-Santos, A.F., Gobira, P.H., Rosa, L.C., Guimaraes, F.S., Moreira, F.A., Aguiar, D.C. · 2013 · Behavioural Brain Research
  89. Cannabis for Chronic Pain: Case Series and Implications for Clinicians
    Ware, Mark A, Gamsa, Ann, Persson, Jan, Fitzcharles, Mary-Ann · 2002 · Pain Research and Management
  90. Role of TRPV1 and cannabinoid CB1 receptors in AM 404-evoked hypothermia in rats
    RAWLS, S, DING, Z, COWAN, A · 2006 · Pharmacology Biochemistry and Behavior
  91. Ex Vivo Imaging of Fatty Acid Amide Hydrolase Activity and Its Inhibition in the Mouse Brain
    Glaser, Sherrye T., Gatley, S. John, Gifford, Andrew N. · 2006 · The Journal of Pharmacology and Experimental Therapeutics
  92. Double dissociation of monoacylglycerol lipase inhibition and CB1 antagonism in the central amygdala, basolateral amygdala, and the interoceptive insular cortex on the affective properties of acute naloxone-precipitated morphine withdrawal in rats
    Wills, Kiri L, Petrie, Gavin N, Millett, Geneva, Limebeer, Cheryl L, Rock, Erin M, Niphakis, Micah J, Cravatt, Benjamin F, Parker, Linda A · 2016 · Neuropsychopharmacology
  93. Preclinical science regarding cannabinoids as analgesics: An overview
    Lynch, ME · 2005 · Pain Research and Management
  94. Role of the endocannabinoid system in metabolic control
    Wang, Jun, Ueda, Natsuo · 2008 · Current Opinion in Nephrology &amp; Hypertension
  95. Genetic analyses of the endocannabinoid pathway in association with affective phenotypic variants
    Lazary, Judit, Eszlari, Nora, Kriko, Eszter, Tozser, Dora, Dome, Peter, Deakin, J. F. William, Juhasz, Gabriella, Bagdy, Gyorgy · 2021 · Neuroscience Letters
  96. Peripheral antinociceptive effect of 2‐arachidonoyl‐glycerol and its interaction with endomorphin‐1 in arthritic rat ankle joints
    Mecs, Laszlo, Tuboly, Gabor, Toth, Kalman, Nagy, Endre, Nyari, Tibor, Benedek, Gyorgy, Horvath, Gyöngyi · 2010 · Clinical and Experimental Pharmacology and Physiology
  97. Acyl Histidines: New N‐Acyl Amides from <i>Legionella pneumophila</i>
    Tørring, Thomas, Shames, Stephanie R., Cho, Wooyoung, Roy, Craig R., Crawford, Jason M. · 2017 · ChemBioChem
  98. Enhancement of apamin-sensitive medium afterhyperpolarization current by anandamide and its role in excitability control in cultured hippocampal neurons
    Wang, Wei, Zhang, Kun, Yan, Sen, Li, Ai, Hu, Xinwu, Zhang, Liangpin, Liu, Changjin · 2011 · Neuropharmacology
  99. ANTINOCICEPTIVE INTERACTIONS BETWEEN ANANDAMIDE AND ENDOMORPHIN‐1 AT THE SPINAL LEVEL
    Tuboly, Gabor, Mecs, Laszlo, Benedek, György, Horvath, Gyöngyi · 2009 · Clinical and Experimental Pharmacology and Physiology
  100. Cannabinoid receptor systems: therapeutic targets for tumour intervention.
    Jones, Sarah, Howl, John · 2003 · Expert Opinion on Therapeutic Targets